Review



mitophagy inhibitor mdivi 1 t1907  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol mitophagy inhibitor mdivi 1 t1907
    Mitophagy Inhibitor Mdivi 1 T1907, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitophagy+inhibitor+mdivi/Mdivi-1/10__1093_slash_lifemeta_slash_loag005-245-86-91
    Average 94 stars, based on 31 article reviews
    mitophagy inhibitor mdivi 1 t1907 - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    99
    MedChemExpress mitophagy inhibitor mdivi 1
    Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM <t>+</t> <t>Mdivi-1</t> groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.
    Mitophagy Inhibitor Mdivi 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitophagy+inhibitor+mdivi/Mdivi-1/pmc13211799-95-5-10
    Average 99 stars, based on 1 article reviews
    mitophagy inhibitor mdivi 1 - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    94
    TargetMol mitophagy inhibitor mdivi 1 t1907
    Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM <t>+</t> <t>Mdivi-1</t> groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.
    Mitophagy Inhibitor Mdivi 1 T1907, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitophagy+inhibitor+mdivi/Mdivi-1/10__1093_slash_lifemeta_slash_loag005-245-86-91
    Average 94 stars, based on 1 article reviews
    mitophagy inhibitor mdivi 1 t1907 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    96
    Selleck Chemicals mitophagy inhibitor mdivi 1
    Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM <t>+</t> <t>Mdivi-1</t> groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.
    Mitophagy Inhibitor Mdivi 1, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitophagy+inhibitor+mdivi/Mdivi-1/pmc12623955-239-24-29
    Average 96 stars, based on 1 article reviews
    mitophagy inhibitor mdivi 1 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    99
    MedChemExpress mitophagy inhibitor
    Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM <t>+</t> <t>Mdivi-1</t> groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.
    Mitophagy Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mitophagy+inhibitor+mdivi/Mdivi-1/pm40188077-91-18-23
    Average 99 stars, based on 1 article reviews
    mitophagy inhibitor - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    Image Search Results


    Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.

    Journal: Neural Regeneration Research

    Article Title: Photobiomodulation repairs the blood–spinal cord barrier in a mouse model of spinal cord injury

    doi: 10.4103/NRR.NRR-D-24-01098

    Figure Lengend Snippet: Inhibition of mitophagy results in increased ROS accumulation in endothelial cells and reverses the therapeutic effects of PBM. (A) Immunoblotting analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in bEnd.3 cells from the Ctrl, OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups. (B–G) Quantitative analysis of LC3, PINK1, Parkin, and TJ protein (ZO-1, Claudin-5, and Occludin) expression in each group of cells ( n = 3 samples per group). (H) Immunofluorescence staining of PINK1 (green, Alexa Fluor 488) in cells from each group. Pretreatment with Mdivi-1 attenuated the PBM-induced increase in expression of the mitophagy-related proteins PINK1 and Parkin, as evidenced by a decrease in the LC3-II/I ratio. Scale bars: 50 μm. (I) Quantification of PINK1 fluorescence intensity in the OGD, OGD + PBM, and OGD + PBM + Mdivi-1 groups relative to the control group ( n = 3 samples per group). (J) JC-1 probe detection of the mitochondrial membrane potential of bEnd.3 cells in each group. Inhibition of mitophagy by Mdivi-1 counteracted the PBM-induced decrease in ΔΨm. Scale bars: 50 μm. (K) Ratio of JC-1 red to JC-1 green fluorescence ( n = 3 samples per group). (L) Dichlorodihydrofluorescein diacetate probe detection of ROS production in each group of bEnd.3 cells. Mdivi-1 treatment increased ROS levels in endothelial cells. (M) Quantification of ROS fluorescence intensity ( n = 3 samples per group). (N) Representative immunofluorescence images of ZO-1 (green, Alexa Fluor 488) in bEnd.3 cells from each group. Administration of Mdivi-1 blocked the PBM-induced increase in ZO-1 and Claudin-5 expression. Scale bars: 50 μm. (O) Quantification of ZO-1 fluorescence ( n = 3 samples per group). (P) Representative immunofluorescence images of Claudin-5 (red, Alexa Fluor 594) in bEnd.3 cells from each group. Pretreatment with Mdivi-1, a mitophagy inhibitor, blocked the PBM-induced increased in expression of the tight junction proteins ZO-1 and Claudin-5. Scale bars: 50 μm. (Q) Quantification of Claudin-5 fluorescence. ( n = 3 samples per group). Data are shown as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). Ctrl: Control; DAPI: 4′,6-diamidino-2-phenylindole; OGD: oxygen-glucose deprivation; PBM: photobiomodulation; PINK1: PTEN-induced kinase 1.

    Article Snippet: Cells were pretreated with the mitophagy inhibitor Mdivi-1 (1 μM, MedChem Express, Monmouth Junction, NJ, USA) for 2 hours prior to exposure to oxygen–glucose deprivation (OGD) and PBM (808 nm, 6 mW/cm 2 , 7 min/time, twice a day).

    Techniques: Inhibition, Western Blot, Expressing, Immunofluorescence, Staining, Fluorescence, Control, Membrane